These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 12799206
1. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro. Vierboom MP, Ossevoort M, Sick EA, Haanstra K, Jonker M. Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206 [Abstract] [Full Text] [Related]
2. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates. Haanstra KG, Ringers J, Sick EA, Ramdien-Murli S, Kuhn EM, Boon L, Jonker M. Transplantation; 2003 Mar 15; 75(5):637-43. PubMed ID: 12640302 [Abstract] [Full Text] [Related]
3. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Bîrsan T, Hausen B, Higgins JP, Hubble RW, Klupp J, Stalder M, Celniker A, Friedrich S, O'Hara RM, Morris RE. Transplantation; 2003 Jun 27; 75(12):2106-13. PubMed ID: 12829920 [Abstract] [Full Text] [Related]
7. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway. Ossevoort MA, Ringers J, Kuhn EM, Boon L, Lorré K, van den Hout Y, Bruijn JA, de Boer M, Jonker M, de Waele P. Transplantation; 1999 Oct 15; 68(7):1010-8. PubMed ID: 10532543 [Abstract] [Full Text] [Related]
8. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86. Kagaya F, Hori J, Kamiya K, Kaji Y, Oshika T, Amano S, Yamagami S, Tsuru T, Tanaka S, Matsuda H, Yagita H, Okumura K. Exp Eye Res; 2002 Jan 15; 74(1):131-9. PubMed ID: 11878826 [Abstract] [Full Text] [Related]
9. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis. Tsai MK, Ho HN, Chien HF, Ou-Yang P, Lee CJ, Lee PH. Transplantation; 2004 Jan 15; 77(1):48-54. PubMed ID: 14724434 [Abstract] [Full Text] [Related]
11. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector. Ziller C, Stoeckel F, Boon L, Haegel-Kronenberger H. Gene Ther; 2002 May 15; 9(9):537-46. PubMed ID: 11973629 [Abstract] [Full Text] [Related]
12. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y, Tang XD, Zhou PJ. Scand J Immunol; 2005 Mar 15; 61(3):266-73. PubMed ID: 15787744 [Abstract] [Full Text] [Related]
13. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons. Boulday G, Ashton-Chess J, Bernard P, Karam G, Vié H, Moreau A, Minault D, Lorré K, Soulillou JP, Blancho G. Nephrol Dial Transplant; 2004 Jul 15; 19(7):1752-60. PubMed ID: 15069178 [Abstract] [Full Text] [Related]
15. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. Gorczynski RM, Cattral MS, Chen Z, Hu J, Lei J, Min WP, Yu G, Ni J. J Immunol; 1999 Aug 01; 163(3):1654-60. PubMed ID: 10415071 [Abstract] [Full Text] [Related]